Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study

British Journal of Cancer

Volumn 112, Issue 3, 2015, Pages 594-600

  Vermeulen, S H ^a   Hanum, N ^a   Grotenhuis, A J ^a   Castano Vinyals G ^b   Van Der Heijden, A G ^a   Aben, K K ^a,c   Mysorekar, I U ^d   Kiemeney, L A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c Comprehensive Cancer Centre the Netherlands ^*  (Netherlands)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bladder infection; urinary bladder cancer; urinary tract infection; urothelial carcinoma

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; IBUPROFEN;

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; CYSTITIS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENOPAUSE; ONSET AGE; PRIORITY JOURNAL; RECURRENT INFECTION; SMOKING; URINARY TRACT INFECTION; AGED; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; NETHERLANDS; RECURRENT DISEASE; RISK FACTOR; URINARY BLADDER NEOPLASMS; URINARY TRACT INFECTIONS;

AGED; CASE-CONTROL STUDIES; CYSTITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RECURRENCE; RISK FACTORS; URINARY BLADDER NEOPLASMS; URINARY TRACT INFECTIONS;

EID: 84922259953     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.601     Document Type: Article

References (31)

1. Claude J, Kunze E, Frentzel-Beyme R, Paczkowski K, Schneider J, Schubert H (1986) Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 124: 578-589
2. Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC (2014) Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer 120: 555-561.
3. Dunham LJ, Rabson AS, Stewart HL, Frank AS, Young JL (1968) Rates interview, and pathology study of cancer of the urinary bladder in New Orleans, Louisiana. J Natl Cancer Inst 41: 683-709.
4. Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, Marsh JV Spear S, Sobel JD, Marty MJ, Marrs CF (2000) Risk factors for second urinary tract infection among college women. Am J Epidemiol 151: 1194-1205.
5. Foxman B (2010) The epidemiology of urinary tract infection. Nat Rev Urol 7: 653-660.
6. Gonzalez CA, Errezola M, Izarzugaza I, Lopez-Abente G, Escolar A, Nebot M Riboli E (1991) Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer 27: 498-500.
7. Henning A, Wehrberger M, Madersbacher S, Pycha A, Martini T, Comploj E Jeschke K, Tripolt C, Rauchenwald M (2013) Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int 112: 68-73.
8. Hess MJ, Zhan EH, Foo DK, Yalla SV (2003) Bladder cancer in patients with spinal cord injury. J Spinal Cord Med 26: 335-338.
9. Howe GR, Burch JD, Miller AB, Cook GM, Esteve G, Morrison B, Gordon P Chambers LW, Fodor G, Winsor GM (1980) Tobacco use, occupation coffee, various nutrients and bladder cancer. J Natl Cancer Inst 64: 701-713.
10. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 61: 1-241.
11. Jhamb M, Lin J, Ballow R, Kamat AM, Grossman HB, Wu X (2007) Urinary tract diseases and bladder cancer risk: a case-control study. Cancer Causes Control 18: 839-845.
12. Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata D, Conti DV, Yuan JM Pike MC, Gago-Dominguez M (2009) Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer 100: 834-839.
13. Kamat AM, Lamm DL (2004) Antitumor activity of common antibiotics against superficial bladder cancer. Urology 63: 457-460.
14. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni Jr JF (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119: 510-515.
15. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN Gudmundsson J, Jakobsdottir M, Bergthorsson JT, Sigurdsson A Blondal T, Witjes JA, Vermeulen SH, Hulsbergen-van de Kaa CA Swinkels DW, Ploeg M, Cornel EB, Vergunst H, Thorgeirsson TE Gudbjartsson D, Gudjonsson SA, Thorleifsson G, Kristinsson KT Mouy M, Snorradottir S, Placidi D, Campagna M, Arici C, Koppova K Gurzau E, Rudnai P, Kellen E, Polidoro S, Guarrera S, Sacerdote C Sanchez M, Saez B, Valdivia G, Ryk C, de Verdier P, Lindblom A, Golka K Bishop DT, Knowles MA, Nikulasson S, Petursdottir V, Jonsson E Geirsson G, Kristjansson B, Mayordomo JI, Steineck G, Porru S, Buntinx F, Zeegers MP, Fletcher T, Kumar R, Matullo G, Vineis P Kiltie AE, Gulcher JR, Thorsteinsdottir U, Kong A, Rafnar T, Stefansson K (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 40: 1307-1312.
16. Kjaer SK, Knudsen JB, Sorensen BL, Moller Jensen O (1989) The Copenhagen case-control study of bladder cancer. V. Review of the role of urinary-tract infection. Acta Oncol 28: 631-636.
17. Kunze E, Chang-Claude J, Frentzel-Beyme R (1992) Life style and occupational risk factors for bladder cancer in Germany. A case-control study. Cancer 69: 1776-1790.
18. La Vecchia C, Negri E, DAvanzo B, Savoldelli R, Franceschi S (1991) Genital and urinary tract diseases and bladder cancer. Cancer Res 51: 629-631.
19. Lin Z, Chen S, Ye C, Zhu S (2003) Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis. Urol Res 31: 232-235.
20. Ma N, Thanan R, Kobayashi H, Hammam O, Wishahi M, El Leithy T Hiraku Y, Amro el-K, Oikawa S, Ohnishi S, Murata M, Kawanishi S (2011) Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection. Biochem Biophys Res Commun 414: 344-349.
21. Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI (2002) Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J Biol Chem 277: 7412-7419.
22. Nicolle LE (2002) Epidemiology of urinary tract infections. Clin Microb Newsletter 18: 135-140.
23. Piper JM, Matanoski GM, Tonascia J (1986) Bladder cancer in young women. Am J Epidemiol 123: 1033-1042.
24. Poljakovic M, Persson K (2003) Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide. Am J Physiol Renal Physiol 284: F22-F31.
25. Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, Torella M (2011) Urinary tract infections in women. Eur J Obstet Gynecol Reprod Biol 156: 131-136.
26. Seay TM, Peretsman SJ, Dixon PS (1996) Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. J Urol 155: 757-762.
27. Sturgeon SR, Hartge P, Silverman DT, Kantor AF, Linehan WM, Lynch C Hoover RN (1994) Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 5: 218-225.
28. Sun LM, Lin CL, Liang JA, Liu SH, Sung FC, Chang YJ, Kao CH (2013) Urinary tract infection increases subsequent urinary tract cancer risk: a population-based cohort study. Cancer Sci 104: 619-623.
29. Swana HS, Smith SD, Perrotta PL, Saito N, Wheeler MA, Weiss RM (1999) Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J Urol 161: 630-634.
30. Wynder EL, Onderdonk J, Mantel N (1963) An epidemiological investigation of cancer of the bladder. Cancer 16: 1388-1407.
31. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG (2002) The role of nitric oxide in cancer. Cell Res 12: 311-320.